The utility of pharmacogenetic testing to support the treatment of bipolar disorder

BACKGROUND: Bipolar disorder (BD) is a frequent cause of disability, health care costs, and risk of suicide. Pharmacogenetic tests (PGTs) could help clinicians to identify those patients predisposed to the occurrence of adverse events (AEs) improving the understanding of the correlation between gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Ielmini, Marta, Poloni, Nicola, Caselli, Ivano, Espadaler, Jordi, Tuson, Miquel, Grecchi, Alessandro, Callegari, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860421/
https://www.ncbi.nlm.nih.gov/pubmed/29588611
http://dx.doi.org/10.2147/PGPM.S160967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860421/
https://www.ncbi.nlm.nih.gov/pubmed/29588611
http://dx.doi.org/10.2147/PGPM.S160967

Ejemplares similares